Clarivate Plc has released a white paper, How is Latin America Growing?, analyzing the pharmaceutical industry’s evolution in the region. The report highlights key challenges and opportunities, focusing on strategic partnerships, local API production, and regulatory modernization as drivers of sustainable growth.

Insights from the Report

Latin America's Pharma Market – Valued at $98 billion, projected 10.1% growth (2021-2025).
Strategic Partnerships – Collaboration among industry stakeholders, regulators, and academia is crucial.
Local API Production – Strengthening regional supply chains reduces external dependency.
Regulatory Modernization – AI-driven processes enhance efficiency and compliance.
Investment & Innovation – Long-term policies are essential for market sustainability.

"Strengthening Latin America's pharmaceutical ecosystem through collaboration and data-driven insights will enhance supply chain resilience and patient access to life-changing therapies." — Henry Levy, President, Life Sciences & Healthcare, Clarivate.

Industry Collaboration & Growth Drivers

Role of ABIQUIFI – Supports local pharmaceutical ingredient production in Brazil.
AI in Regulatory Processes – Improves efficiency & modernization.
Data-Driven Decision-Making – Enhances innovation & competitiveness.
Public-Private Partnerships – Key to sustained industry growth.

"By investing in local API production and strengthening supply chains, Latin America can emerge as a key global player in pharmaceuticals." — Norberto Prestes, CEO, ABIQUIFI.